Abstract
Although Meyerozyma guilliermondii complex is an uncommon cause of invasive candidiasis worldwide, reported cases, mainly regarding bloodstream infections, increased over years, and patients with cancer who have undergone recent surgery are most commonly affected. However, the clinical characteristics and outcomes of candidemia caused by M. guilliermondii complex remain poorly understood. A retrospective case–control study was conducted to evaluate the clinical characteristics and mortality of candidemia caused by M. guilliermondii complex in cancer patients undergoing surgery. Demographic and clinical data were collected from the hospital medical records system with a standardized data collection form and were analyzed with SPSS 20.0. Sixty-six cancer patients who have undergone recent surgery and were diagnosed with candidemia caused by M. guilliermondii complex were included in the study. Regarding the clinical manifestations, most patients’ body temperatures ranged from 38 to 40 °C, with a median fever duration of 4 (IQR: 3–6) days. Multivariate analysis indicated that the presence of central venous catheter (OR: 6.68; 95% CI 2.80–15.94) and gastric tube (OR: 3.55; 95% CI 1.22–10.34) were independent risk factors for M. guilliermondii complex fungemia. The 30-day crude mortality of candidemia caused by M. guilliermondii complex was 12.1%, twice that of the control group. Moreover, increased WBC count, age ≥ 60 years, septic shock, and ICU admission were identified as predictors of mortality through univariate analysis. These findings will provide a foundation for the clinical management of candidemia caused by M. guilliermondii complex in post-surgical cancer patients.
Similar content being viewed by others
Availability of Data and Material
In supplemental materials.
Code Availability
WHONET 5.6 was used.
References
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Executive summary: clinical practice guideline for the management of Candidiasis: 2016 update by the infectious diseases Society of America. Clin Infect Dis. 2016;62(4):409–17. https://doi.org/10.1093/cid/civ1194.
Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, et al. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study. Intensive Care Med. 2017;43(4):509–18. https://doi.org/10.1007/s00134-017-4717-0.
Luzzati R, Cavinato S, Deiana ML, Rosin C, Maurel C, Borelli M. Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards. Aging Clin Exp Res. 2015;27(2):131–7. https://doi.org/10.1007/s40520-014-0251-x.
Tascini C, Sozio E, Corte L, Sbrana F, Scarparo C, Ripoli A, et al. The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data. Infect Dis (Lond). 2018;50(3):214–9. https://doi.org/10.1080/23744235.2017.1384956.
Jia X, Li C, Cao J, Wu X, Zhang L. Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study. Eur J Clin Microbiol Infect Dis. 2018;37(9):1717–24. https://doi.org/10.1007/s10096-018-3304-9.
Polke M, Hube B, Jacobsen ID. Candida survival strategies. Adv Appl Microbiol. 2015;91:139–235. https://doi.org/10.1016/bs.aambs.2014.12.002.
Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288–305. https://doi.org/10.1111/j.1574-6976.2011.00278.x.
Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, et al. Clinical and microbiological characteristics of Candida guilliermondii and Candida fermentati. Antimicrob Agents Chemother. 2018. https://doi.org/10.1128/AAC.02528-17.
Ahangarkani F, Badali H, Rezai MS, Shokohi T, Abtahian Z, Mahmoodi Nesheli H, et al. Candidemia due to Candida guilliermondii in an immuno-compromised infant: a case report and review of literature. Curr Med Mycol. 2019;5(1):32–6. https://doi.org/10.18502/cmm.5.1.535.
Pfaller MA, Diekema DJ, Mendez M, Kibbler C, Erzsebet P, Chang SC, et al. Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol. 2006;44(10):3551–6. https://doi.org/10.1128/JCM.00865-06.
Orsetti E, Brescini L, Mazzanti S, Trave F, Morroni G, Masucci A, et al. Characterisation of candidemia in patients with recent surgery: a 7-year experience. Mycoses. 2019;62(11):1056–63. https://doi.org/10.1111/myc.12988.
Stelling JM, O’Brien TF. Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis. 1997;24(Suppl 1):S157–68. https://doi.org/10.1093/clinids/24.supplement_1.s157.
Pfaller MA, Diekema DJ. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol. 2012;50(9):2846–56. https://doi.org/10.1128/JCM.00937-12.
Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F, et al. The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med. 2017;43(5):652–62. https://doi.org/10.1007/s00134-017-4743-y.
Vaezi A, Fakhim H, Khodavaisy S, Alizadeh A, Nazeri M, Soleimani A, et al. Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis. J de Mycol Med. 2017;27(2):146–52. https://doi.org/10.1016/j.mycmed.2017.02.007.
Sun C, Fang H, Xie T, Auth RD, Patel N, Murray PR, et al. Anthrax lethal toxin disrupts intestinal barrier function and causes systemic infections with enteric bacteria. PLoS ONE. 2012;7(3):e33583. https://doi.org/10.1371/journal.pone.0033583.
Tadec L, Talarmin JP, Gastinne T, Bretonniere C, Miegeville M, Le Pape P, et al. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study. Mycoses. 2016;59(5):296–303. https://doi.org/10.1111/myc.12470.
Puzniak L, Teutsch S, Powderly W, Polish L. Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol. 2004;25(8):628–33. https://doi.org/10.1086/502452.
Phoompoung P, Chayakulkeeree M. Recent progress in the diagnosis of pathogenic Candida species in blood culture. Mycopathologia. 2016;181(5–6):363–9. https://doi.org/10.1007/s11046-016-0003-x.
Wickes BL, Wiederhold NP. Molecular diagnostics in medical mycology. Nat Commun. 2018;9(1):5135. https://doi.org/10.1038/s41467-018-07556-5.
Marcos-Zambrano LJ, Puig-Asensio M, Perez-Garcia F, Escribano P, Sanchez-Carrillo C, Zaragoza O, et al. Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of Candidemia. Antimicrob Agents Chemother. 2017. https://doi.org/10.1128/AAC.00099-17.
Tseng TY, Chen TC, Ho CM, Lin PC, Chou CH, Tsai CT, et al. Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: an experience in a tertiary hospital in mid-Taiwan. J Microbiol Immunol Infect. 2018;51(4):552–8. https://doi.org/10.1016/j.jmii.2016.08.015.
Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med. 2014;40(9):1303–12. https://doi.org/10.1007/s00134-014-3408-3.
Sbrana F, Sozio E, Bassetti M, Ripoli A, Pieralli F, Azzini AM, et al. Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards. Intern Emerg Med. 2018;13(2):199–204. https://doi.org/10.1007/s11739-017-1783-9.
McCarthy MW, Walsh TJ. Candidemia in the cancer patient: diagnosis, treatment, and future directions. Expert Rev Anti Infect Ther. 2018;16(11):849–54. https://doi.org/10.1080/14787210.2018.1536546.
Tsai HY, Lee MH, Wan CH, Yang LY, Yen TC, Tseng JR. C-reactive protein levels can predict positive (18)F-FDG PET/CT findings that lead to management changes in patients with bacteremia. J Microbiol Immunol Infect. 2018;51(6):839–46. https://doi.org/10.1016/j.jmii.2018.08.003.
Kim HW, Ku S, Jeong SJ, Jin SJ, Han SH, Choi JY, et al. Delta neutrophil index: could it predict mortality in patients with bacteraemia? Scand J Infect Dis. 2012;44(7):475–80. https://doi.org/10.3109/00365548.2012.657232.
Cheng JW, Yu SY, Xiao M, Wang H, Kudinha T, Kong F, et al. Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China. J Clin Microbiol. 2016;54(8):2187–9. https://doi.org/10.1128/JCM.00938-16.
Cheng JW, Liao K, Kudinha T, Yu SY, Xiao M, Wang H, et al. Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system. Sci Rep. 2017;7(1):907. https://doi.org/10.1038/s41598-017-01106-7.
Acknowledgements
We appreciate Hengrui Liang from the Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, for kindly assisting with manuscript revision.
Funding
This work was supported by the Laboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences (2019RU017) and National Key Specialist Construction Project for Clinical Laboratory Medicine.
Author information
Authors and Affiliations
Contributions
Yunzhuo Chu conceived and designed the study; Jingjing Chen and Fushun Li collected the data; Sufei Tian and Ke Yun analyzed the data; Jingjing Chen, Shitong Cheng, and Guoquan Sun wrote the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflict of interest.
Ethics Approval
This study was approved by the Medical Ethics Committees of the First Hospital of China Medical University.
Consent to Participate
Not applicable.
Consent for Publication
Written informed consent for publication was obtained from all participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Handling editor: Patrick CY Woo.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, J., Tian, S., Li, F. et al. Clinical Characteristics and Outcomes of Candidemia Caused by Meyerozyma guilliermondii Complex in Cancer Patients Undergoing Surgery. Mycopathologia 185, 975–982 (2020). https://doi.org/10.1007/s11046-020-00485-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-020-00485-2